LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Clinical trial NCT06632444 · RECRUITING

Trial details

NCT number: NCT06632444
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis

Start date: 2024-09-17
Primary completion: 2031-12-27
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.